013390000a22003610004500003000900000005001700009020001500026090001500041100003700056264007100093490005700164700003200221700002800253700003100281700002500312700003000337700002900367700004000396700002900436710003900465245011000504300001000614041000800624650003900632650002900671650004200700650003100742650004000773040001100813942003600824999001700860952010000877PH-MaWHO20241108112606.0  a3456820275  aUJ.RB 1993  aGrof, Paul... [ et al.].9668531  aBern : bHogrefe and Huber Publishers on behalf of the WHO,c1993.  aWHO expert series on biological psychiatry ; vol. 2.  aAkhter, M. Iftikhar9668532  aCampbell, Magda9668533  aGottfries, Carl G.9668534  aKhan, Inayat9652885  aLapierre, Yvon D.9668535  aLemberger, Louis9668536  aMnller-Oerlinghausen, Bruno9668537  aWoggon, Brigitte9668538  aWorld Health Organization.9641634  aClinical evaluation of psychotropic drugs for psychiatric disorders : principles and proposed guidelines.  a202p.  aeng  aDrug EvaluationxStandards9139406  aDrug utilization9139634  aMental disordersxDrug therapy981341  aPsychotropic drugs9292119  aSubstance-related disorders9448064  aWHOLIS  cMONOgMark 13-10-2008  11:12:24  c13974d13974  00104070aWPRObWPROd2021-05-24l0oUJ.RB 1993p13974r2024-01-24 00:00:00w2021-05-24yMONO